Cite
HARVARD Citation
Ahmadzadehfar, H. et al. (2018). BRCA2 Mutation as a Possible Cause of Poor Response to 177Lu-PSMA Therapy. Clinical nuclear medicine. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ahmadzadehfar, H. et al. (2018). BRCA2 Mutation as a Possible Cause of Poor Response to 177Lu-PSMA Therapy. Clinical nuclear medicine. p. . [Online].